Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20201117001
TCTR20201117001
Completed
未知

Evaluation of Adverse Events and Health-Related Quality of Life in Patients with Colorectal Cancer Receiving Ambulatory Home-Based Chemotherapy in Thailand

Ramathibodi Hospital, Mahidol University0 sites175 target enrollmentNovember 17, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsncontrolled underlying of heart disease&#44DM&#44hypertension&#44and cognitive imparement

Overview

Phase
未知
Intervention
Not specified
Conditions
ncontrolled underlying of heart disease&#44
Sponsor
Ramathibodi Hospital, Mahidol University
Enrollment
175
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 17, 2020
End Date
May 25, 2017
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Ramathibodi Hospital, Mahidol University

Eligibility Criteria

Inclusion Criteria

  • •1\. Colorectal cancer patient
  • •2\. Treatment: oxaliplatin/leucovirin/5\-fluorouracil (mFOLFOX) and
  • •Irinotecan/leucovirin/5\-fluorouracil (FOLFIRI) with 5\-fluorouracil contrnuous infusion for 48\-50 hours (both regimens)
  • •3\. Good ECOG performance status \<3
  • •4\. Good compliance
  • •5\. Signed consent form

Exclusion Criteria

  • •1\. Uncontrolled underlying disease
  • •2\. Cognitive impairment (it might be impacted of selfcare and device care at home)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Suspended
Not Applicable
Menopause and ManagementHealth Condition 1: null- Pre menopausal, menopausal and postmenopausal patients
CTRI/2017/09/009856Charutar Vidya Mandal
Completed
Not Applicable
nderstanding the health effects and susceptibility factors of circadian misaligngment
JPRN-UMIN000025744ational Center of Neurology and Psychiatry30
Recruiting
Not Applicable
The evaluation of adverse events and theraputic effects using divided CDDP for advanced urothelial carcinoma patients with Chronic Kidney Disease.rothelial Carcinoma
JPRN-UMIN000009202agoya Univerity, Depatment of Urology20
Recruiting
Phase 4
Evaluation the possible side effects of rivaroxaban in patients with pulmonary valve replacement or Fontan surgery.
IRCT20220516054868N2Esfahan University of Medical Sciences75
Not yet recruiting
Not Applicable
Association between adverse events and prognosis in postoperative adjuvant chemotherapy for colorectal cancerColorectal cancer
JPRN-UMIN000047961Japanese Foundation for Multidisciplinary Treatment of Cancer4,212